A new therapeutic drug formulation (TDF) comprising of low doses of commercial equine anti-scorpion antivenom (ASA), α1- adrenoreceptor agonist (AAAs) and vitamin C, for inhibiting the Indian red scorpion venom-induced toxicity and associated symptom